BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2004
View Archived Issues
Vasogen highlights FY 2003 developments
Read More
CuraGen continues to advance pipeline of protein, antibody and small molecule therapeutics
Read More
Low levels of free testosterone may increase risk of Alzheimer disease
Read More
Migraine sufferers with aura and at least one attack per month at risk for cerebral infarction
Read More
CE Mark for Matritech NMP22 products
Read More
Ivax's generic glyburide/metformin hydrochloride receives approval
Read More
Pfizer discontinues development of DK-507k
Read More
GeneMax acquires license to novel assay technology
Read More
Enrollment completed in phase IIa IPL-512602 study
Read More
OraDisc A NDA accepted for filing
Read More
Phenanthrene-based glucocorticoid receptor modulators newly developed at Pfizer
Read More
Alrex safe for long-term treatment of seasonal allergic conjunctivitis
Read More
Novel cholesterol absorption inhibitors discovered at AstraZeneca
Read More
Novartis presents new modulators of Smac/IAP interaction
Read More
New tubulysin conjugates for cancer therapy claimed by Morphochem
Read More
Phase I trial of PT-523 commences enrollment
Read More
New protein kinase inhibitors for cancer therapy designed at Novartis
Read More
Novartis presents novel tyrosine kinase inhibitors with utility in leukemia
Read More
New antitumor fredericamycin derivatives discovered at Biofrontera
Read More
New program for Protherics' Angiotensin Vaccine
Read More
Novel probucol derivatives with improved PK profile presented by AtheroGenics team
Read More
Surfaxin selected for CMA Pilot 2 Program
Read More
Clinical benefits induced by roflumilast in the treatment of asthma
Read More
Promising phase III results found for indiplon in chronic insomnia
Read More
Preliminary efficacy results of a Zadaxin triple therapy in hepatitis C
Read More
Poor efficacy reported for vaccines against HIV infection
Read More
Yamanouchi and Fujisawa announce agreement to merge in 2005
Read More
NPC1L1 identified as a protein involved in intestinal cholesterol absorption and action of ezetimibe
Read More